Relevance of G protein-coupled receptor (GPCR) dynamics for receptor activation, signalling bias and allosteric modulation
- PMID: 38978399
- DOI: 10.1111/bph.16495
Relevance of G protein-coupled receptor (GPCR) dynamics for receptor activation, signalling bias and allosteric modulation
Abstract
G protein-coupled receptors (GPCRs) are one of the major drug targets. In recent years, computational drug design for GPCRs has mainly focused on static structures obtained through X-ray crystallography, cryogenic electron microscopy (cryo-EM) or in silico modelling as a starting point for virtual screening campaigns. However, GPCRs are highly flexible entities with the ability to adopt different conformational states that elicit different physiological responses. Including this knowledge in the drug discovery pipeline can help to tailor novel conformation-specific drugs with an improved therapeutic profile. In this review, we outline our current knowledge about GPCR dynamics that is relevant for receptor activation, signalling bias and allosteric modulation. Ultimately, we highlight new technological implementations such as time-resolved X-ray crystallography and cryo-EM as well as computational algorithms that can contribute to a more comprehensive understanding of receptor dynamics and its relevance for GPCR functionality. LINKED ARTICLES: This article is part of a themed issue Complexity of GPCR Modulation and Signaling (ERNST). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v182.14/issuetoc.
Keywords: Allosteric modulation; Drug design; GPCR dynamics; Molecular dynamics simulations; Signalling bias; Time‐resolved experimental techniques.
© 2024 The Author(s). British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
References
REFERENCES
-
- Alexander, S. P. H., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A. A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., & Davies, J. A. (2023). The concise guide to PHARMACOLOGY 2023/24: G protein‐coupled receptors. British Journal of Pharmacology, 180(Suppl 2), S23–S144.
-
- Arnold, C. (2023). Inside the nascent industry of AI‐designed drugs. Nature Medicine, 29, 1292–1295. https://doi.org/10.1038/s41591-023-02361-0
-
- Bueno, A. B., Showalter, A. D., Wainscott, D. B., Stutsman, C., Marín, A., Ficorilli, J., Cabrera, O., Willard, F. S., & Sloop, K. W. (2016). Positive allosteric modulation of the glucagon‐like peptide‐1 receptor by diverse electrophiles. The Journal of Biological Chemistry, 291, 10700–10715. https://doi.org/10.1074/jbc.M115.696039
-
- Calderón, J. C., Ibrahim, P., Gobbo, D., Gervasio, F. L., & Clark, T. (2023). General metadynamics protocol to simulate activation/deactivation of class A GPCRs: Proof of principle for the serotonin receptor. Journal of Chemical Information and Modeling, 63, 3105–3117. https://doi.org/10.1021/acs.jcim.3c00208
-
- Cao, A.‐M., Quast, R. B., Fatemi, F., Rondard, P., Pin, J.‐P., & Margeat, E. (2021). Allosteric modulators enhance agonist efficacy by increasing the residence time of a GPCR in the active state. Nature Communications, 12, 5426. https://doi.org/10.1038/s41467-021-25620-5
Publication types
MeSH terms
Substances
Grants and funding
- 101080465/Horizon Europe Project Obelisk
- PI18/00094/Instituto de Salud Carlos III FEDER
- AC18/00030/ERA-NET NEURON & Ministry of Economy, Industry, and Competitiveness
- CD22/00007/Institute of Health Carlos III (ISCIII)
- 2021 SGR 00046/Agència de Gestió d'Ajuts Universitaris i de Recerca Generalitat de Catalunya (AGAUR)
LinkOut - more resources
Full Text Sources